These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7811843)

  • 21. Severe depression: is there a best approach?
    Sonawalla SB; Fava M
    CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output.
    Golden RN; Markey SP; Risby ED; Rudorfer MV; Cowdry RW; Potter WZ
    Arch Gen Psychiatry; 1988 Feb; 45(2):150-4. PubMed ID: 3122700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant drug selection: criteria and options.
    Preskorn SH
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():6-22; discussion 23-4, 98-100. PubMed ID: 7961544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current antidepressant drugs: their clinical use.
    Hollister LE
    Drugs; 1981 Aug; 22(2):129-52. PubMed ID: 6114851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH
    Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent developments in geriatric psychopharmacotherapy.
    Flint AJ
    Can J Psychiatry; 1994 Oct; 39(8 Suppl 1):S9-18. PubMed ID: 7828123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological treatment of depression].
    Castro P; Wilmotte J
    Rev Med Brux; 1994; 15(5):306-10. PubMed ID: 7984847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inadequate dosaging in general practice of tricyclic vs. other antidepressants for depression.
    Isometsä E; Seppälä I; Henriksson M; Kekki P; Lönnqvist J
    Acta Psychiatr Scand; 1998 Dec; 98(6):451-4. PubMed ID: 9879786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants.
    Malki K; Uher R; Paya-Cano J; Binder E; Rietschel M; Zobel A; Mors O; Hauser J; Henigsberg N; Jerman B; Souery D; Placentino A; Ng MY; Cohen-Woods S; Sluyter F; Farmer A; Aitchison KJ; Craig IW; Lewis CM; McGuffin P; Schalkwyk LC
    Biol Psychiatry; 2011 Feb; 69(4):360-5. PubMed ID: 20970119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug resistance in endogenous depression. Part I. Refractoriness to antidepressants in patients with depression admitted to a psychiatric clinic for the first time].
    Puzyński S; Koszewska I; Kalinowski A; Bogdanowicz E; Swiecicki L
    Psychiatr Pol; 1993; 27(6):673-82. PubMed ID: 8134501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dose tranylcypromine therapy for refractory depression.
    Amsterdam JD; Berwish NJ
    Pharmacopsychiatry; 1989 Jan; 22(1):21-5. PubMed ID: 2710808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
    Ricken R; Ulrich S; Schlattmann P; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of drug response in depression.
    Joyce PR; Paykel ES
    Arch Gen Psychiatry; 1989 Jan; 46(1):89-99. PubMed ID: 2562916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans.
    Gassen NC; Hartmann J; Zschocke J; Stepan J; Hafner K; Zellner A; Kirmeier T; Kollmannsberger L; Wagner KV; Dedic N; Balsevich G; Deussing JM; Kloiber S; Lucae S; Holsboer F; Eder M; Uhr M; Ising M; Schmidt MV; Rein T
    PLoS Med; 2014 Nov; 11(11):e1001755. PubMed ID: 25386878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and antidepressants and the elderly.
    Busse E; Simpson D
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):35-9. PubMed ID: 6343362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits and limitations of major pharmacological treatment for depression.
    Georgotas A; McCue RE
    Am J Psychother; 1986 Jul; 40(3):370-6. PubMed ID: 3766819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological management of treatment-resistant depression.
    Shaw DM
    Psychopharmacol Ser; 1988; 5():118-29. PubMed ID: 3045795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.
    Perlis RH; Fijal B; Dharia S; Heinloth AN; Houston JP
    Biol Psychiatry; 2010 Jun; 67(11):1110-3. PubMed ID: 20110084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.